menu
    • menu

    Company profile for Ncardia

    NEW Drugs in Dev: 1
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We apply human iPSC expertise and commercial cell manufacturing experience to cell therapy by designing and delivering iPSC solutions to your requirements. Offerings include basic research, proof of concept studies, process development and large-scale custom manufacturing of a range of cell types.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NcardiaBelgium Flag
    Country
    Country
    Belgium
    Address
    Address
    47 Rue Adrienne Bolland 6041 Gosselies
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ncardia.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ncardia
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/NcardiaStemCell

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ncardia Introduces Ipsc-Derived Non-Human Primate Cardiomyocytes
    Ncardia Introduces Ipsc-Derived Non-Human Primate Cardiomyocytes

    23 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-23/ncardia-launches-first-of-its-kind-ipsc-derived-non-human-primate-cardiomyocytes-to-advance-cardiac

    PHARMAWEB
    23 Sep 2025
    Share Share
    Ncardia Launch Ncyte Microglia to Research in Neurodegenerative
    Ncardia Launch Ncyte Microglia to Research in Neurodegenerative

    27 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250127745999/en

    BUSINESSWIRE
    27 Jan 2025
    Share Share
    Ncardia Launch Ncyte Heart in Box to Research & Precision Medicine
    Ncardia Launch Ncyte Heart in Box to Research & Precision Medicine

    27 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250127115777/en

    BUSINESSWIRE
    27 Jan 2025
    Share Share
    Ncardia Launches Ready-to-Use Therapeutic Screening Assays
    Ncardia Launches Ready-to-Use Therapeutic Screening Assays

    10 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240910211628/en

    BUSINESSWIRE
    10 Sep 2024
    Share Share
    Ncardia Launches Cellistic to Make Large-scale Allogeneic Cell Therapy
    Ncardia Launches Cellistic to Make Large-scale Allogeneic Cell Therapy

    19 Apr 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220419005253/en

    BUSINESSWIRE
    19 Apr 2022
    Share Share
    Ncardia Appoints Andy Holt as Chief Commercial Officer
    Ncardia Appoints Andy Holt as Chief Commercial Officer

    24 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220224005123/en

    BUSINESSWIRE
    24 Feb 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search